In focus · trending topic

Oak Therapeutics

1 stories · following the connections

Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis

By Nasdaq OMXOct 3, 2017, 1:00 PM UTC